Tcrx Therapeutics Co.ltd
Clinical trials sponsored by Tcrx Therapeutics Co.ltd, explained in plain language.
-
New personalized cell therapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a personalized treatment called KXV01 TCR Lentinvivo for people with advanced solid tumors that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified to better recognize and attack cancer. The main goals a…
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
New gene therapy trial targets hard-to-treat cancers
Disease control Not yet recruitingThis early-stage study tests a new treatment called KXV01 TCR Lentinvivo in 30 adults with advanced solid tumors that have not responded to standard therapies. The main goal is to check safety and find the right dose. Participants receive a single infusion of genetically modified…
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated May 22, 2026 14:03 UTC